XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.54−0.08 (-4.94%)
Close on Nov 18, 2026Market cap $14.57MP/E –Yield –
XTL Biopharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
XTL Biopharmaceuticals's price to sales ratio was 64.0× on Feb 27, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Feb 27, 2026 | 64.0× | +18.7 |
| 2025 | Dec 31, 2025 | 45.3× | – |
See a number that looks wrong?